Try our corporate solution for free!

Number of active disease-modifying Alzheimer's drug trials globally in 2019, by phase

Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Single Account

$39 $59 per month *
in the first 12 months
33% off until Sep 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

May 2019



Survey time period

February 28, 2019

Supplementary notes

* Twelve programs listed as “Ex-US” in the Biomedtracker database are included here by phase based on independent research of company websites. This “Ex-US” listing implies the companies have not yet intended to seek FDA approval. No NDA/BLA filings were active for Alzheimer’s Disease as of February 28, 2019. Only novel approaches with disease modifying potential in Alzheimer’s disease are shown.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Alzheimer's and other dementias"

Further Content: You might find this interesting as well


Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.